High rates of pulmonary artery occlusions in COVID‐19. A meta‐analysis

Background COVID‐19 patients are considered at high risk of venous thromboembolism (VTE). The real nature of pulmonary artery occlusions (PAO) in COVID‐19 has been questioned, suggesting that it is caused also by in situ thrombi, rather than only by emboli (PE) from peripheral thrombi. Methods We se...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical investigation Jg. 51; H. 1; S. e13433 - n/a
Hauptverfasser:	Birocchi, Simone, Manzoni, Marco, Podda, Gian Marco, Casazza, Giovanni, Cattaneo, Marco
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Blackwell Publishing Ltd 01.01.2021 John Wiley and Sons Inc
Schlagworte:	Anticoagulants - therapeutic use Case-Control Studies COVID-19 COVID-19 - epidemiology embolism and thrombosis Heparin Heparin - therapeutic use Heparin, Low-Molecular-Weight - therapeutic use Humans low‐molecular‐weight heparin Meta-analysis Original Original Papers Prevalence Pulmonary arteries Pulmonary Artery Pulmonary Embolism - epidemiology Pulmonary Embolism - prevention & control SARS coronavirus SARS-CoV-2 Thromboembolism Thrombosis Thrombosis - epidemiology Thrombosis - prevention & control Venous Thrombosis - epidemiology Venous Thrombosis - prevention & control COVID-19 low-molecular-weight heparin embolism and thrombosis SARS coronavirus
ISSN:	0014-2972, 1365-2362, 1365-2362
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!